Live data from Hacker News

Viewing profile — rexroad

rexroad

HN member
Joined
Mon, Mar 16, 2026, 3:43 PM UTC
HN karma
265
Public activity
45 items

About rexroad

Data journalist investigating US healthcare costs. Former [your background if relevant]. Building open-source analyses of CMS, OECD, and federal hospital data. Code at github.com/rexrodeo/american-healthcare-conundrum

Recent public activity

  1. story
  2. story
  3. comment
  4. story
  5. comment
    Comment #47655848

    Author here. This is Issue #6 of The American Healthcare Conundrum, a data-driven newsletter that analyzes CMS cost report data to find where U.S. healthcare dollars actually go. F…

  6. story
  7. comment
  8. comment
  9. comment
    Comment #47506300

    CMS now requires hospitals to publish machine-readable price files under the Hospital Price Transparency Rule (effective 2021, enforcement added 2022). Compliance rates are technic…

  10. comment
    Comment #47506275

    Agreed on the diagnosis: the inpatient hospital market does not function as a competitive market. Patients arriving by ambulance do not shop on price. Insurance insulates consumers…

  11. comment
    Comment #47506244

    For-profit structure is part of the problem but not all of it. Issue 3 analyzed 3,193 hospitals using CMS HCRIS FY2023 cost reports. For-profit hospitals do have the highest cost-t…

  12. comment
    Comment #47506225

    The direction is right. Total US healthcare spending is $4.87T for 335M people ($14,570/capita, CMS NHE 2023). Japan's per-capita is $5,790, with the highest life expectancy in the…

  13. comment
  14. story
  15. comment
    Comment #47492989

    Thanks for sharing the OSU piece, good read. A few things it surfaces that complicate the "discount cards help patients" narrative: discount card companies still contract with PBMs…

  16. comment
    Comment #47492868

    Your example captures two distinct extraction mechanisms in one transaction. The $25 to $125 gap is spread pricing: the PBM pockets the difference between what they pay the pharmac…

  17. comment
  18. comment
    Comment #47480794

    Author here. Issue #4 is now live — pharmacy benefit managers. Three companies process 80% of US prescriptions. The FTC spent two years investigating them and documented $7.3B in s…

  19. comment
    Comment #47478179

    The NHS prices in the Issue #2 analysis are not subsidies. They are the generic reimbursement rates from the UK Drug Tariff after patent expiry on each molecule. Apixaban (Eliquis)…

  20. comment
    Comment #47478156

    The data supports this. The AMA's 2024 Prior Authorization survey found 93% of physicians report PA requirements delay medically necessary care. Twenty-nine percent reported a PA d…

  21. comment
  22. comment
    Comment #47454964

    The RAND Round 5.1 study (2023) puts US commercial insurer payments at 254% of Medicare rates for identical procedures. That's the mechanism behind the international gaps — it's no…

  23. comment
  24. comment
  25. comment